HSPA5 and cancer: Our data showed that indeed GRP78 plays a pivotal role in MDR acquisition because SK-Hep-1 cells were relatively more vulnerable to be eradicated by these ROS-producing anti-cancer drugs owing to the deficiency of GRP78 expression (Figure 5).